ClearStream/Cordis PTA (percutaneous transluminal angioplasty) balloon catheter deal expands:
This article was originally published in Clinica
Johnson & Johnson-subsidiary Cordis is to offer a broader range of percutaneous transluminal angioplasty (PTA) balloon catheters in its Sleek and Savvy Long lines, following the expansion of an existing agreement with the devices' manufacturer ClearStream Technologies. Cordis' endovascular division has been marketing Sleek and Savvy Long balloons of up to 200mm in length outside the US since May 2007. It expects the new catheters - which include lengths of up to 220mm - to be available in non-US market from October 2007, and in the US in the first quarter of 2008.
You may also be interested in...
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.